A commentary by Calvin Meaney urges discontinuation of outdated tests that are imprecise or disadvantage Black patients.
Everyday Health on MSN
C3G/IC-MPGN progression: Can new C3 inhibitors stop the path to dialysis?
For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of ...
But it wasn't until he started to feel an odd pain that he thought something was off, too. "I started to get a little bit of upper right rib cage pain that I thought was an abdominal muscle," he says.
Stockhead on MSN
Racura secures green light for RC220 HARNESS-1 lung cancer trial
Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an update on its ongoing regulatory interactions with the U.S. Food and Drug ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...
Zacks.com on MSN
BAYRY Reports Positive Data on Kidney Drug in Non-Diabetic CKD
Bayer BAYRY announced that finerenone achieved the primary endpoint in the late-stage FIND-CKD study, marking a key milestone ...
Dr Kathryn Fox is an Australian medical doctor and bestselling crime writer, best known for her forensic thrillers featuring ...
Diabetes is one of the leading causes of kidney disease worldwide, and India carries a particularly high burden of both conditions. What makes diabetic kidney disease especially concerning is that it ...
A Diaceutics report looks at when in the diagnosis, testing, and treatment process NSCLC patients lose out on access to precision medicine.
When Chadwick Boseman died in August 2020 at the age of 43, the world learned that the beloved star of Black Panther had ...
Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results